Speaker illustration

Doctor Emma Robinson

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

After graduating from Oxford University in Biochemistry in 2010, Emma moved to the University of Cambridge where she was awarded a Wellcome Trust PhD fellowship in Cardiovascular and Metabolic Disease and carried out her PhD under the supervision of LLewelyn Roderick at The Babraham Institute, Cambridge. In 2014, the lab moved to KU Leuven in Belgium, alongside Karin Sipido. Here, Emma won an International scholarship from the KU Leuven Faculty of Medicine. Emma was awarded her PhD in Biological Sciences from Emmanuel college, University of Cambridge in 2018. In 2018, Emma joined the lab of Stephane Heymans at Maastricht University in the Netherlands. She went on to win a Talent programme grant from the Dutch Heart Foundation as well as a Postdoc award from the International Society for Heart Failure Research. In autumn 2020, Emma will move to join the lab of Tim McKinsey at the University of Colorado in Denver, U.S. to continue her work on epigenetic mechanisms in heart failure.

Epigenetic Drugs: Targeting the ‘Heart’ of Cardiovascular Remodeling

Event: ESC Congress 2020

Topic: Basic Science

Session type: Special Session


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb